Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2005 2
2007 1
2009 1
2011 2
2012 1
2013 1
2022 1
2023 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
IL28B polymorphism and the control of hepatitis C virus infection: ready for clinical use?
Orlent H, Reynaert H, Bourgeois S, Dideberg V, Adler M, Colle I, De Maeght S, Laleman W, Michielsen P, Moreno C, Mulkay JP, Stärkel P, Delwaide J; Belgian Association for the Study of the Liver. Orlent H, et al. Acta Gastroenterol Belg. 2011 Jun;74(2):317-22. Acta Gastroenterol Belg. 2011. PMID: 21861317 Free article. Review.
Update of the Belgian Association for the Study of the Liver guidelines for the treatment of chronic hepatitis C genotype 1 with protease inhibitors.
Orlent H, Deltenre P, Francque S, Laleman W, Moreno C, Bourgeois S, Colle I, Delwaide J, De Maeght S, Mulkay JP, Stärkel P, Reynaert H; Belgian Association for the Study of the Liver. Orlent H, et al. Acta Gastroenterol Belg. 2012 Jun;75(2):245-59. Acta Gastroenterol Belg. 2012. PMID: 22870791 Free article. No abstract available.
High prevalence of advanced fibrosis in association with the metabolic syndrome in a Belgian prospective cohort of NAFLD patients with elevated ALT. Results of the Belgian NAFLD registry.
Francque S, De Maeght S, Adler M, Deltenre P, de Galocsy C, Orlent H, Van Steenbergen W, Bastens B, Wain E, Langlet P, Lasser L, Verlinden W, Van Marck E, Henrion J; Steering Committee of the Belgian Association for the Study of the Liver. Francque S, et al. Acta Gastroenterol Belg. 2011 Mar;74(1):9-16. Acta Gastroenterol Belg. 2011. PMID: 21563648 Free article.
Guidelines for the management of chronic hepatitis C in patients infected after substance use.
Robaeys G, Buntinx F, Bottieau E, Bourgeois S, Brenard R, Colle I, De Bie J, Matheï C, Mulkay JP, Van Damme P, Van Ranst M, Verrando R, Michielsen P, Bourgeois N, Brenard R, de Galocsy Ch, Delwaide J, Henrion J, Horsmans Y, Michielsen P, Reynaert H, Robaeys G, Sprengers D; Steering Committee of the Belgian Association for the Study of the Liver (BASL). Robaeys G, et al. Acta Gastroenterol Belg. 2005 Jan-Mar;68(1):38-45. Acta Gastroenterol Belg. 2005. PMID: 15832586 Review. No abstract available.
Management and treatment of chronic hepatitis B virus: Belgian Association for the Study of the Liver (BASL) 2007 guidelines.
Colle I, Adler M, Brenard R, Henrion J, Langlet P, Michielsen P, Orlent H, Reynaert H, Sprengers D, Stärkel P, Van Damme P, Verslype C, Delwaide J; Belgian Association for the Study of the Liver. Colle I, et al. Acta Gastroenterol Belg. 2007 Oct-Dec;70(4):389-420. Acta Gastroenterol Belg. 2007. PMID: 18330099 No abstract available.
Viral clade is associated with severity of symptomatic genotype 3 hepatitis E virus infections in Belgium, 2010-2018.
Peeters M, Schenk J, De Somer T, Roskams T, Locus T, Klamer S, Subissi L, Suin V, Delwaide J, Stärkel P, De Maeght S, Willems P, Colle I, Van Hoof M, Van Acker J, Van Steenkiste C, Moreno C, Janssens F, Reynders M, Steverlynck M, Verlinden W, Lasser L, de Galocsy C, Geerts A, Maus J, Gallant M, Van Outryve S, Marot A, Reynaert H, Decaestecker J, Bottieau E, Schreiber J, Mulkay JP, de Goeij S, Salame M, Dooremont D, Dastis SN, Boes J, Nijs J, Beyls J, Hens N, Nevens F, Van Gucht S, Vanwolleghem T; Belgian Association for the Study of the Liver. Peeters M, et al. J Hepatol. 2023 Jan;78(1):67-77. doi: 10.1016/j.jhep.2022.08.033. Epub 2022 Sep 6. J Hepatol. 2023. PMID: 36075495 Free article.
Treatment of chronic hepatitis C in patients with human immunodeficiency virus (HIV) with weekly peginterferon alpha-2b plus ribavirin: a multi-centred Belgian study.
Michielsen P, Bottieau E, Van Vlierberghe H, Van Marck E, Vandemaele E, Denys M, Brasseur JP, Popan M; Steering Committee of the Belgian Association for the Study of the Liver. Michielsen P, et al. Acta Gastroenterol Belg. 2009 Oct-Dec;72(4):389-93. Acta Gastroenterol Belg. 2009. PMID: 20163031
Treatment of acute hepatitis C with interferon alpha-2b: early initiation of treatment is the most effective predictive factor of sustained viral response.
Delwaide J, Bourgeois N, Gérard C, De Maeght S, Mokaddem F, Wain E, Bastens B, Fevery J, Géhénot M, Le Moine O, Martinet JP, Robaeys G, Servais B, Van Gossum M, Van Vlierberghe H; Belgian Association for the Study of the Liver (BASL). Delwaide J, et al. Aliment Pharmacol Ther. 2004 Jul 1;20(1):15-22. doi: 10.1111/j.1365-2036.2004.02023.x. Aliment Pharmacol Ther. 2004. PMID: 15225166 Free article. Clinical Trial.
12 results